HIM
DMAQR

HGC Investment Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

HGC Investment Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-600,000
Closed -$88K – 391
2022
Q2 		$88K Buy
600,000
+300,000
+100% +$48.8K ﹤0.01% 337
2022
Q1 		$54K Hold
300,000
– – ﹤0.01% 299
2021
Q4 		$96K Buy
+300,000
New +$94.9K 0.01% 297

Other funds holding DMAQR

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HGC Investment Management's DMAQR Position: Q3 2022 in Review

HGC Investment Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q3 2022, closing a stake of 600,000 shares — an estimated $88K sold.

HGC Investment Management first reported a position in DMAQR in Q4 2021 and held it in 3 quarters. The position peaked at $96K in Q4 2021. 30 funds tracked by Wall St. Rank hold DMAQR as of Q3 2022.

  • HGC Investment Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q3 2022 after selling out during the quarter.
  • HGC Investment Management sold 600,000 Deep Medicine Acquisition Corp. Rights shares in Q3 2022, an estimated $88K.
  • HGC Investment Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 3 quarters.
  • HGC Investment Management's Deep Medicine Acquisition Corp. Rights position peaked at $96K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q3 2022.

Based on HGC Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.